These studies were conducted at the Centre for Genetic Hematology in Thi-Qar governorate during the period of November 2024 until February 2024. This study aims to determine thalassemia through all aspects (age, gender, place of residence) as well as the prevalence of thalassemia and the control group according to ABO. It is also the relationship of thalassemia with patients with spleen hyperplasia and hepectomy. the Study have including (40) patients with thalassemia beta divided between (25 males) and (15 females). Patients are divided into three age groups (14 to 34 years old), the first group ranges from (14 to 20) years, the second group ranges from (21 to 27) years, and the third group between (28 to 34) years, the dominant age group was 20 (40.0%) 12 males and 8 females while the first age group is 15 (30.0%) 8 males and 7 females ,the second age group is 15 (30.0%) 8 males and 7 females. According to the study conducted on sex, there is no significant difference between the sexes, while thalassemia is a genetic disease that is transmitted from parents to offspring. Through the study of the ABO system, these results also showed that there are no significant differences between blood groups within one sex between (males and females). The questionnaire shows that all patients over the age of 20 have undergone spleen removal but with regard to hepatitis, there is no infection for all patients.
No takes yet. Share an insight, caveat, or question.
Noor Kadhim Abed (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: